(WASHINGTON)Federal antitrust regulators on Tuesday cleared Eli Lilly & Co.'s $50 million sale of a research facility to drug development services provider Covance Inc.READ MORE
Among the sector activity stories for Wednesday, Aug. 6, from AP Financial News: NEW YORK (AP)--Shares of refiners soared Wednesday as crude prices continued their downward march o...READ MORE
INDIANAPOLIS--Drug-development services company Covance Inc. will buy an Indiana research center from Eli Lilly and Co. and enter a 10-year service deal with the drug maker worth $...READ MORE
(NEW YORK)Shares of clinical research companies including Kendle International Inc. and Covance Inc. outpaced the broader market Wednesday as continued demand for outsourced drug development...READ MORE
(NEW YORK)Shares of Illumina Inc. and Edwards Lifesciences hit new 52-week highs Wednesday, as a Cowen & Co. analyst said a potential increase in the National Institute of Health's fisca...READ MORE
Among the stock activity stories for Wednesday, June 25, from AP Financial News: NEW YORK (AP)--Shares of WuXi Pharmatech Inc. surged Wednesday after the Chinese drug development s...READ MORE
(NEW YORK)Shares of WuXi Pharmatech surged Wednesday after the Chinese drug development services company said it will create a joint venture with its American peer Covance Inc.READ MORE